SNHG18 and central nervous system cancer: Indeed, previous studies in cancers have shown that SNHG18 promotes FOXD1 expression by decoying miR-338-5p,75 suppresses nucleocytoplasmic transport of α-enolase,32 and inhibits semaphorin 5A31 in glioma cells.